News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,747 Results
Type
Article (44243)
Company Profile (249)
Press Release (600255)
Multimedia
Podcasts (91)
Webinars (12)
Section
Business (182344)
Career Advice (2625)
Deals (34008)
Drug Delivery (121)
Drug Development (79529)
Employer Resources (168)
FDA (16001)
Job Trends (14855)
News (320808)
Policy (32835)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (5)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (10)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (3)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2592)
Accelerated approval (5)
Adcomms (27)
Allergies (87)
Alliances (45690)
ALS (96)
Alzheimer's disease (1408)
Antibody-drug conjugate (ADC) (145)
Approvals (15985)
Artificial intelligence (269)
Autoimmune disease (25)
Automation (15)
Bankruptcy (339)
Best Places to Work (11327)
BIOSECURE Act (21)
Biosimilars (112)
Biotechnology (154)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (286)
Cancer (2294)
Cardiovascular disease (195)
Career advice (2202)
Career pathing (34)
CAR-T (164)
Cell therapy (445)
Cervical cancer (20)
Clinical research (65078)
Collaboration (825)
Compensation (487)
Complete response letters (29)
COVID-19 (2653)
CRISPR (43)
C-suite (238)
Cystic fibrosis (96)
Data (2176)
Decentralized trials (2)
Denatured (25)
Depression (51)
Diabetes (278)
Diagnostics (6110)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (39)
Drug discovery (121)
Drug pricing (116)
Drug shortages (29)
Duchenne muscular dystrophy (95)
Earnings (71794)
Editorial (41)
Employer branding (22)
Employer resources (146)
Events (98691)
Executive appointments (717)
FDA (17223)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (740)
Gene editing (106)
Generative AI (25)
Gene therapy (320)
GLP-1 (773)
Government (4475)
Grass and pollen (6)
Guidances (51)
Healthcare (18537)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (132)
Indications (30)
Infectious disease (2799)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (99)
Interviews (459)
IPO (16071)
IRA (45)
Job creations (3933)
Job search strategy (1850)
Kidney cancer (11)
Labor market (36)
Layoffs (523)
Leadership (22)
Legal (7933)
Liver cancer (76)
Lung cancer (333)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (317)
MASH (73)
Medical device (12495)
Medtech (12500)
Mergers & acquisitions (18488)
Metabolic disorders (727)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (105)
Neuropsychiatric disorders (34)
Neuroscience (1978)
NextGen: Class of 2025 (6512)
Non-profit (4405)
Northern California (2559)
Now hiring (32)
Obesity (384)
Opinion (250)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (82)
Parkinson's disease (153)
Partnered (20)
Patents (234)
Patient recruitment (109)
Peanut (50)
People (53672)
Pharmaceutical (84)
Pharmacy benefit managers (21)
Phase I (19850)
Phase II (28769)
Phase III (21937)
Pipeline (1198)
Policy (152)
Postmarket research (2407)
Preclinical (7944)
Press Release (50)
Prostate cancer (106)
Psychedelics (37)
Radiopharmaceuticals (248)
Rare diseases (394)
Real estate (5844)
Recruiting (69)
Regulatory (22590)
Reports (34)
Research institute (2335)
Resumes & cover letters (428)
Rett syndrome (4)
RNA editing (4)
RSV (45)
Schizophrenia (77)
Series A (133)
Series B (83)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2177)
Special edition (16)
Spinal muscular atrophy (149)
Sponsored (31)
Startups (3654)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (38)
The Weekly (64)
United States (22100)
Vaccines (734)
Venture capitalists (41)
Weight loss (273)
Women's health (27)
Worklife (19)
Date
Today (190)
Last 7 days (865)
Last 30 days (2614)
Last 365 days (32638)
2025 (10282)
2024 (34857)
2023 (39380)
2022 (49901)
2021 (54363)
2020 (52845)
2019 (45423)
2018 (34436)
2017 (31894)
2016 (30651)
2015 (35396)
2014 (27453)
2013 (26184)
2012 (23869)
2011 (24666)
2010 (22127)
Location
Africa (856)
Alabama (53)
Alaska (7)
Arizona (154)
Arkansas (14)
Asia (39868)
Australia (6405)
California (5807)
Canada (1954)
China (532)
Colorado (255)
Connecticut (268)
Delaware (135)
Europe (85904)
Florida (892)
Georgia (176)
Idaho (47)
Illinois (516)
India (25)
Indiana (282)
Iowa (10)
Japan (158)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (60)
Maryland (825)
Massachusetts (4376)
Michigan (202)
Minnesota (350)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (24)
Nevada (64)
New Hampshire (66)
New Jersey (1670)
New Mexico (29)
New York (1682)
North Carolina (1006)
North Dakota (7)
Northern California (2559)
Ohio (190)
Oklahoma (13)
Oregon (34)
Pennsylvania (1336)
Puerto Rico (13)
Rhode Island (30)
South America (1185)
South Carolina (20)
South Dakota (1)
Southern California (2177)
Tennessee (98)
Texas (866)
Utah (167)
Virginia (156)
Washington D.C. (60)
Washington State (541)
West Virginia (3)
Wisconsin (48)
644,747 Results for "sta pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
Milestone Scientific Inc. today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group, a premier group of 21 dental practices across the northeastern United States.
February 20, 2024
·
4 min read
Pharm Country
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
Milestone Scientific Inc. announces it has commenced direct sales of its STA Single Tooth Anesthesia System® with Meridian Endo & Perio, a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.
February 28, 2024
·
4 min read
Press Releases
Ocugen Announces Completion of Dosing in Subjects with Stargardt Disease in High Dose Cohort of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
August 28, 2024
·
5 min read
Business
Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
Milestone Scientific Inc. today announced it has entered into a distribution agreement granting TEKMIKA Health Technologies exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System ® (STA) in Brazil.
January 10, 2023
·
4 min read
Drug Development
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
Ocugen, Inc. announced that dosing is complete in the second cohort of its Phase 1/2 GARDian clinical trial for OCU410ST —a modifier gene therapy candidate being developed for Stargardt disease as a one-time treatment for life.
May 15, 2024
·
5 min read
Press Releases
Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba™ in the state of Illinois
April 30, 2025
·
7 min read
Press Releases
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
April 22, 2025
·
4 min read
Press Releases
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
April 3, 2025
·
7 min read
Business
WuXi STA and Multiply Labs Announce Partnership and Successfully Deploy Robotic Manufacturing System for Personalized Drugs
WuXi STA, a subsidiary of WuXi AppTec and a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the partnership with Multiply Labs (based in San Francisco, CA, USA), a robotics company that has developed industry-leading automated manufacturing systems to produce individualized drugs.
December 1, 2022
·
5 min read
Press Releases
Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies
April 24, 2025
·
3 min read
1 of 64,475
Next
